Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Cytogenetics is a technology that studies the structure and function of a cell (chromosome) and gene abnormalities in a disease. Molecular cytogenetics is a combination of molecular biology and cytogenetics.

Statistics:

The global molecular cytogenetics market is estimated to account for US$ 11,129.1 Mn in terms of value by the end of 2027.

Global Molecular Cytogenetics Market: Drivers

Increasing adoption of molecular cytogenetics is expected to propel growth of the global molecular cytogenetics market over the forecast period. For instance, in October 2019, Bionano Genomics, Inc. announced that leading organizations, including PerkinElmer Genomics and the University of Iowa, have adopted Saphyr for use in their clinical genomics laboratories.

Moreover, increasing prevalence of cancer is also expected to boost adoption of molecular cytogenetics. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Statistics:

North America held dominant position in the global molecular cytogenetics market in 2019, accounting for 45.7% share in terms of value, followed by Europe and Asia Pacific, respectively.

Figure 1: Global Molecular Cytogenetics Market Share (%) Value, By Region, 2019

Molecular Cytogenetics  | Coherent Market Insights

Global Molecular Cytogenetics Market: Restraints

Unfavorable reimbursement policies represent a major restraint for the growth of global molecular cytogenetics market. Insurance companies are refraining from reimbursing molecular diagnostic tests.

Moreover, high cost of genetic testing is also expected to limit the market growth. The cost of these tests typically range from US$ 300 to US$ 3,000 per test and are considered the most important technologies for early detection.

request-sample

Molecular Cytogenetics Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 1,970.8 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 24.2% 2027 Value Projection: US$ 11,129.1 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
  • Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: North Africa, Central Africa, South Africa
Segments covered:
  • By Technology: FISH, aCGH.
  • By Application: Genetic Disorder, Cancer, Personalized Medicine, Others.
Companies covered:

Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., BI Biological Industries, Bio-Rad Laboratories, CytoTest Inc., Cytognomix, Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Bionano Genomics, Inc., Precipio, Inc., and Leica Biosystems

Growth Drivers:
  • Increasing prevalence of cancer
  • Approval and launch of new products
Restraints & Challenges:
  • Unfavorable reimbursement policies

Global Molecular Cytogenetics Market: Opportunities 

Tapping in emerging economies is expected to offer lucrative growth opportunities for players in the global molecular cytogenetics market. FISH and array based technologies have high penetration rate in developed economies such as the U.S and Europe owing to high level of public awareness and adoption rate. However, emerging Asian and Latin American economies have low adoption rate owing to low patient awareness levels. Economic developments in these regions coupled with rising disposable income of patients and increasing awareness are shifting the attention of medical practitioners towards molecular tests.

Moreover, rising incidence of cancer and genetic disorders in emerging economies is also expected to boost demand for molecular cytogenetic technologies in these regions. For instance, according to the World Health Organization, the number of new cancer cases diagnosed per year in Africa is expected to grow from over 1 million in 2018 to over 2.1 million in 2040.

Statistics:

The global molecular cytogenetics market was valued at US$ 1,970.8 Mn in 2019 and is forecast to reach a value of US$ 11,129.1 Mn by 2027 at a CAGR of 24.2% between 2020 and 2027.

Figure 2: Global Molecular Cytogenetics Market Value (US$ Mn), 2016 – 2027

Molecular Cytogenetics  | Coherent Market Insights

Market Trends/Key Takeaways

Availability of effective molecular cytogenetic systems is expected to propel growth of the global molecular cytogenetics market. For instance, in July 2020, two top cytogeneticists from leading institutions in The Netherlands and France reported that Bionano Genomics' Saphyr demonstrates 100% concordance to standard cytogenetics in genetic disorders.

Moreover, launch of novel NGS panel is also expected to aid in growth of the market. For instance, in February 2020, Oxford Gene Technology launched The CytoSure Constitutional NGS Panel, a transformative next-generation sequencing (NGS) panel for constitutional cytogenetics research.

Global Molecular Cytogenetics Market: Competitive Landscape

Major players operating in the global molecular cytogenetics market include, Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., BI Biological Industries, Bio-Rad Laboratories, CytoTest Inc., Cytognomix, Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Bionano Genomics, Inc., Precipio, Inc., and Leica Biosystems.

Global Molecular Cytogenetics Market: Key Developments

Major players in the global molecular cytogenetics market are focused on launching new products to expand their product portfolio. For instance, in March 2020, Agilent Technologies Inc. launched three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research.

Molecular cytogenetics encompasses the combination of molecular biology and cytogenetics. It enables to differentiate normal and cancer causing cells. Molecular cytogenetics helps to study the structural and functional organization of chromosomes and its nucleus, genomic variations, expression and evolution, and chromosomal abnormalities in medicinal and cancer-related genetics. High prevalence of cancer and increasing application of molecular biology in detection of inherited susceptibilities associated with cancer development is expected to boost the molecular cytogenetics market growth.

Key features of the study:

  • This report provides in-depth analysis of the Global Molecular Cytogenetics market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Molecular Cytogenetics market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., BI Biological Industries, Bio-Rad Laboratories, CytoTest Inc., Cytognomix, Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Bionano Genomics, Inc., Precipio, Inc., and Leica Biosystems
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Molecular Cytogenetics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Molecular Cytogenetics market

Detailed Segmentation:

  • Global Molecular Cytogenetics Market, By Technology:
    • FISH
    • aCGH
  • Global Molecular Cytogenetics Market, By Application:
    • Genetic Disorders
    • Cancer
    • Personalized Medicine
    • Others
  • Global Molecular Cytogenetics Market, By Region:
    • North America
      • By Technology:
        • FISH
        • aCGH
      • By Application
        • Genetic Disorders
        • Cancer
        • Personalized Medicine
        • Others
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Technology:
        • FISH
        • aCGH
      • By Application
        • Genetic Disorders
        • Cancer
        • Personalized Medicine
        • Others
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Technology:
        • FISH
        • aCGH
      • By Application
        • Genetic Disorders
        • Cancer
        • Personalized Medicine
        • Others
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Technology:
        • FISH
        • aCGH
      • By Application
        • Genetic Disorders
        • Cancer
        • Personalized Medicine
        • Others
      • By Country
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Technology:
        • FISH
        • aCGH
      • By Application
        • Genetic Disorders
        • Cancer
        • Personalized Medicine
        • Others
      • By Country
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • By Technology:
        • FISH
        • aCGH
      • By Application
        • Genetic Disorders
        • Cancer
        • Personalized Medicine
        • Others
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Abbott Laboratories *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Affymetrix, Inc.
    • Agilent Technologies, Inc.,
    • Applied Spectral Imaging, Inc.
    • BI Biological Industries
    • Bio-Rad Laboratories
    • CytoTest Inc.
    • Cytognomix Inc.
    • F. Hoffmann-La Roche Ltd.
    • Illumina Inc.
    • Bionano Genomics, Inc.
    • Precipio, Inc.
    • Leica Biosystems
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Application
      • Market Snippet, By Country
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Global Molecular Cytogenetics Market, By Technology, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • FISH
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • aCGH
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Molecular Cytogenetics Market, By Application, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Genetic Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Personalized Medicine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Molecular Cytogenetics Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Technology, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Affymetrix, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Agilent Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Applied Spectral Imaging, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • BI Biological Industries
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bio-Rad Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • CytoTest Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cytognomix, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • F. Hoffmann-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Illumina Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bionano Genomics, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Precipio, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Leica Biosystems
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 14 figures on “Molecular Cytogenetics Market - Global forecast to 2027”.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner